Cargando…
The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback
Clinical evidence suggests that symptoms in premenstrual dysphoric disorder (PMDD) reflect abnormal responsivity to ovarian steroids. This differential steroid sensitivity could be underpinned by abnormal processing of the steroid signal. We used a pharmacometabolomics approach in women with prospec...
Autores principales: | Nguyen, T V, Reuter, J M, Gaikwad, N W, Rotroff, D M, Kucera, H R, Motsinger-Reif, A, Smith, C P, Nieman, L K, Rubinow, D R, Kaddurah-Daouk, R, Schmidt, P J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611719/ https://www.ncbi.nlm.nih.gov/pubmed/28786978 http://dx.doi.org/10.1038/tp.2017.146 |
Ejemplares similares
-
Altered estradiol-dependent cellular Ca(2+) homeostasis and endoplasmic reticulum stress response in Premenstrual Dysphoric Disorder
por: Li, Howard J., et al.
Publicado: (2021) -
The Cerebellum and Premenstrual Dysphoric Disorder
por: Rapkin, Andrea J., et al.
Publicado: (2014) -
Premenstrual Syndrome and Premenstrual Dysphoric Disorder in Perimenopausal Women
por: Chung, Soo-Ho, et al.
Publicado: (2014) -
Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol
por: De Berardis, Domenico, et al.
Publicado: (2007) -
Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder
por: Yen, Ju-Yu, et al.
Publicado: (2019)